Disc Medicine: Funding, Investors & Team (Sep 2026)
Disc Medicine is led by an experienced team of scientists and industry experts, and supported by a panel of advisors with a strong track record of discovering and developing new and innovative therapies. Disc Medicine was founded by Atlas Venture and Brian MacDonald, with Novo Ventures and Access Biotechnology joining as additional investors.
Disc Medicine has raised $158M across 2 funding rounds on record, the most recent an undisclosed round of $158M announced in Jun 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Disc Medicine Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Disc Medicine Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Disc Medicine announced an undisclosed round in Aug 2022; the amount was not disclosed.
10 months later, an undisclosed round of $158M was announced in Jun 2023.
Disc Medicine Founders and Leadership Team
No contact details are on record for this team yet.
Disc Medicine Funding Compared to Other Biotechnology Startups
Disc Medicine's latest round of $158M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Disc Medicine in Biotechnology and Cambridge
Companies Similar to Disc Medicine
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Disc Medicine Funding FAQs
What does Disc Medicine do?
Disc Medicine is led by an experienced team of scientists and industry experts, and supported by a panel of advisors with a strong track record of discovering and developing new and innovative therapies. Disc Medicine was founded by Atlas Venture and Brian MacDonald, with Novo Ventures and Access Biotechnology joining as additional investors.
How much funding has Disc Medicine raised?
Disc Medicine has raised $158M across 2 rounds on record. The most recent is an undisclosed round of $158M announced in Jun 2023.
When did Disc Medicine last raise funding?
Disc Medicine's most recent funding round on record is an undisclosed round of $158M, announced in Jun 2023.
Who founded Disc Medicine?
FundedIQ lists Brian Macdonald (Founder) at Disc Medicine.
Who is the CEO of Disc Medicine?
John Quisel is listed as CEO at Disc Medicine.
Where is Disc Medicine headquartered?
Disc Medicine is based in Cambridge, Massachusetts, United States.
How many employees does Disc Medicine have?
Disc Medicine is in the 11-50 employee band.
How does Disc Medicine's funding compare to other Biotechnology startups?
Disc Medicine's latest round of $158M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Disc Medicine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Disc Medicine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.